TCAs, SNRIs, and alpha-2-delta ligands remain first-line treatments for neuropathic pain, while newer options like rTMS and ...

Explore new neuropathic pain therapies in this new study, and discover key updates and clinical recommendations.

Background: Neuropathic pain is one ... appeared most beneficial: complete pain relief in 5/25, partial relief in 17/25, and no benefit in 3/25 patients. Phenytoin resulted in complete relief ...